<VariationArchive VariationID="2943983" VariationName="NM_000834.5(GRIN2B):c.2352_2359+2dup" VariationType="Duplication" Accession="VCV002943983" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3101154" VariationID="2943983">
      <GeneList>
        <Gene Symbol="GRIN2B" FullName="glutamate ionotropic receptor NMDA type subunit 2B" GeneID="2904" HGNC_ID="HGNC:4586" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="13537337" stop="13982134" display_start="13537337" display_stop="13982134" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="13714409" stop="14133021" display_start="13714409" display_stop="14133021" Strand="-" />
          </Location>
          <OMIM>138252</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GRIN2B">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GRIN2B">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000834.5(GRIN2B):c.2352_2359+2dup</Name>
      <CanonicalSPDI>NC_000012.12:13569827:ACCATCTCCAA:ACCATCTCCAACCATCTCCAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="13569827" stop="13569828" display_start="13569827" display_stop="13569828" variantLength="10" positionVCF="13569827" referenceAlleleVCF="C" alternateAlleleVCF="CACCATCTCCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="13722761" stop="13722762" display_start="13722761" display_stop="13722762" variantLength="10" positionVCF="13722761" referenceAlleleVCF="C" alternateAlleleVCF="CACCATCTCCA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.13722763_13722772dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.13722763_13722772dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.13569829_13569838dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.13569829_13569838dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031854.2" sequenceAccession="NG_031854" sequenceVersion="2" change="g.417176_417185dup">
            <Expression>NG_031854.2:g.417176_417185dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001413992.1" sequenceAccession="NM_001413992" sequenceVersion="1" change="c.2352_2359+2dup">
            <Expression>NM_001413992.1:c.2352_2359+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000834.5" sequenceAccession="NM_000834" sequenceVersion="5" change="c.2352_2359+2dup" MANESelect="true">
            <Expression>NM_000834.5:c.2352_2359+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000834.5(GRIN2B):c.2352_2359+2dup AND multiple conditions" Accession="RCV003803541" Version="1">
        <ClassifiedConditionList TraitSetID="21888">
          <ClassifiedCondition DB="MedGen" ID="C4015316">Developmental and epileptic encephalopathy, 27</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3151411">Intellectual disability, autosomal dominant 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="21888" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32574" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 27</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 27</ElementValue>
                <XRef ID="MONDO:0014505" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE27</ElementValue>
                <XRef Type="MIM" ID="616139" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">GRIN2B-related neurodevelopmental disorder is characterized by mild to profound developmental delay / intellectual disability (DD/ID) in all affected individuals. Muscle tone abnormalities (spasticity and/or hypotonia, occasionally associated with feeding difficulties), as well as epilepsy and autism spectrum disorder (ASD) / behavioral issues, are common. Other infantile- or childhood-onset findings include microcephaly; dystonic, dyskinetic, or choreiform movement disorder; and/or cortical visual impairment. Brain MRI reveals a malformation of cortical development in a minority of affected individuals. To date, fewer than 100 individuals with GRIN2B-related neurodevelopmental disorder have been reported.</Attribute>
                <XRef ID="NBK501979" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16063" />
                <XRef ID="16063" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29851452</ID>
                <ID Source="BookShelf">NBK501979</ID>
              </Citation>
              <XRef ID="3451" DB="Orphanet" />
              <XRef ID="C4015316" DB="MedGen" />
              <XRef ID="MONDO:0014505" DB="MONDO" />
              <XRef Type="MIM" ID="616139" DB="OMIM" />
            </Trait>
            <Trait ID="16103" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES</ElementValue>
                <XRef Type="MIM" ID="613970" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, autosomal dominant 6</ElementValue>
                <XRef ID="MONDO:0013509" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRD6</ElementValue>
                <XRef Type="MIM" ID="613970" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">GRIN2B-related neurodevelopmental disorder is characterized by mild to profound developmental delay / intellectual disability (DD/ID) in all affected individuals. Muscle tone abnormalities (spasticity and/or hypotonia, occasionally associated with feeding difficulties), as well as epilepsy and autism spectrum disorder (ASD) / behavioral issues, are common. Other infantile- or childhood-onset findings include microcephaly; dystonic, dyskinetic, or choreiform movement disorder; and/or cortical visual impairment. Brain MRI reveals a malformation of cortical development in a minority of affected individuals. To date, fewer than 100 individuals with GRIN2B-related neurodevelopmental disorder have been reported.</Attribute>
                <XRef ID="NBK501979" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12851" />
                <XRef ID="12851" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29851452</ID>
                <ID Source="BookShelf">NBK501979</ID>
              </Citation>
              <XRef ID="C3151411" DB="MedGen" />
              <XRef ID="MONDO:0013509" DB="MONDO" />
              <XRef Type="MIM" ID="613970" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8547064" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="18324086|MedGen:CN224183;C3151411" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004593489" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has been observed in individual(s) with clinical features of GRIN2B-related conditions (Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 11 of the GRIN2B gene. It does not directly change the encoded amino acid sequence of the GRIN2B protein. It affects a nucleotide within the consensus splice site.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRIN2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.13722761_13722762insACCATCTCCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN224183" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3151411" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8547064" TraitType="Disease" MappingType="XRef" MappingValue="CN224183" MappingRef="MedGen">
        <MedGen CUI="C4015316" Name="Developmental and epileptic encephalopathy, 27" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8547064" TraitType="Disease" MappingType="XRef" MappingValue="C3151411" MappingRef="MedGen">
        <MedGen CUI="C3151411" Name="Intellectual disability, autosomal dominant 6" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

